+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Devices Market - Global Forecast 2026-2032- Product Image
Drug Delivery Devices Market - Global Forecast 2026-2032- Product Image
Sale

Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337868
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Delivery Devices Market is projected to reach USD 470.89 Million in 2026. It is expected to continue growing at a CAGR of 8.40%, reaching USD 767.54 Million by 2032.

Drug delivery devices are moving from product features to care-enabling platforms as chronic disease, biologics, and home-based treatment reshape demand. WHO reports that noncommunicable diseases account for about 74% of global deaths, while the International Diabetes Federation estimates 537 million adults were living with diabetes in 2021, creating sustained need for insulin pens, autoinjectors, infusion pumps, inhalers, prefilled syringes, and wearable injectors.

Growth is being driven by patient convenience, dose accuracy, therapy adherence, and the migration of injectable and inhaled therapies outside hospitals. For manufacturers, competitive edge increasingly depends on human factors engineering, connected device capabilities, combination-product compliance, cybersecurity, and scalable global manufacturing.

Transformative Shifts in the Drug Delivery Device Landscape

The drug delivery device landscape is shifting toward self-administration, connected care, and device-drug integration. Biologics and specialty medicines require delivery systems that protect sensitive formulations, enable controlled dosing, and reduce administration burden. At the same time, value-based healthcare is increasing the focus on adherence evidence, real-world outcomes, and reduced total cost of care.

Regulatory expectations are also transforming strategy. FDA combination-product oversight, EU Medical Device Regulation requirements, ISO 11608 standards for needle-based injection systems, and IEC 62304 software lifecycle controls are pushing companies to design safer, more traceable, and more digitally resilient devices.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across the drug delivery device value chain. AI supports early design simulation, failure-mode analysis, automated visual inspection, predictive maintenance, and signal detection from connected inhalers, pumps, pens, and wearable injectors. These applications can reduce quality variation and accelerate evidence generation when governed by validated data pipelines.

The largest strategic impact will come from AI-enabled personalization, including adherence prediction, dose-support tools, and patient-risk stratification. However, adoption must align with FDA cybersecurity guidance, software as a medical device principles, data privacy rules, and auditable model governance to maintain trust and regulatory defensibility.

Key Regional Insights

Asia-Pacific is advancing on the strength of large diabetic and respiratory patient populations, local manufacturing capacity, and rising access to biologics in China, India, Japan, South Korea, and Australia. WHO identifies Asia-Pacific countries as major contributors to global noncommunicable disease burden, while aging demographics in Japan, South Korea, and China are increasing demand for easy-to-use injectors, inhalers, prefilled syringes, and home-based infusion technologies. North America remains a high-value innovation hub, supported by FDA-regulated combination products, advanced reimbursement pathways, strong clinical trial infrastructure, and demand for connected autoinjectors, insulin pumps, smart inhalers, and wearable injectors.

Europe benefits from established pharmaceutical manufacturing, EU MDR harmonization, strong pharmacovigilance systems, and sustainability expectations for device design, including growing pressure to reduce plastic waste and improve lifecycle management. Latin America is progressing through diabetes care modernization, expanding private-sector access, and broader use of injectable therapies in Mexico and Brazil. The Middle East is investing in specialty care infrastructure, digital health, and chronic disease management programs, particularly across high-income Gulf health systems. Africa remains earlier stage, with opportunities tied to essential medicines access, cold-chain reliability, donor-supported health programs, and affordable device formats suited to decentralized care delivery.

Key Group Insights

ASEAN is becoming more important for manufacturing diversification, medical technology assembly, and diabetes care access, with Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines supporting regional supply networks and healthcare modernization. The GCC is prioritizing specialty clinics, digital health, and chronic disease programs amid high diabetes and obesity burdens reported across the region, creating demand for premium injectors, connected adherence tools, and hospital-to-home delivery models.

The European Union is shaping global compliance through MDR, sustainability policy, data protection standards, and coordinated health technology assessment priorities. BRICS countries offer scale through large patient pools, localization policies, and expanding domestic medtech capabilities, particularly in China, India, and Brazil. G7 markets lead in reimbursement sophistication, clinical adoption of biologics, regulatory science, and connected drug delivery innovation. NATO economies are increasingly emphasizing supply-chain resilience for critical medicines, polymers, electronics, needles, sensors, and device components as healthcare systems prioritize continuity of access.

Key Country Insights

The United States leads in connected drug delivery innovation, specialty biologics, and FDA-regulated combination products, supported by strong adoption of autoinjectors, insulin pumps, smart inhalers, and digital adherence solutions. Canada emphasizes public coverage, safety, and equitable access, with demand shaped by chronic disease management and alignment with international regulatory expectations. Mexico and Brazil are important Latin American growth markets due to diabetes prevalence, expanding private healthcare, public-sector procurement needs, and regional manufacturing potential. The United Kingdom, Germany, France, Italy, and Spain remain central to European adoption through strong pharmaceutical ecosystems, clinical infrastructure, aging populations, and established pathways for injectable and inhalation therapies.

Russia continues to prioritize local production and supply security, while China and India provide scale, cost competitiveness, expanding domestic device manufacturing, and rising demand for insulin delivery, respiratory drug delivery, and biologic administration systems. Japan and South Korea lead in precision engineering, aging-population needs, digital health readiness, and high-quality device manufacturing. Australia supports advanced care pathways, connected health uptake, chronic disease management programs, and regulatory alignment with international medical device standards, making it a strong reference market for safe, patient-centered drug delivery devices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize modular drug delivery device platforms that can support multiple formulations, dose volumes, viscosities, and patient populations. Human factors validation, usability for elderly patients, needle-safety features, low-force activation, dose confirmation, and minimized administration steps should be embedded early to reduce development risk and improve adoption.

Companies should also invest in connected-device cybersecurity, AI governance, sustainable materials, supplier redundancy, and localized regulatory strategies. Partnerships with pharmaceutical developers, contract manufacturers, digital health specialists, healthcare providers, and patient-support programs can accelerate evidence generation, improve adherence, strengthen market access, and support lifecycle differentiation without compromising safety or compliance.

Research Methodology

This executive summary is grounded in secondary research from recognized public sources, including WHO, International Diabetes Federation, FDA, EMA, ISO, IEC, OECD, World Bank, and national regulatory agencies. Insights were structured around disease burden, device innovation, regulatory standards, healthcare delivery trends, regional market maturity, chronic disease management, and the adoption of self-administration technologies.

The analysis applies triangulation across regulatory publications, clinical-care trends, demographic datasets, reimbursement signals, public health indicators, and supply-chain evidence. Emphasis was placed on verified directional evidence rather than unsupported market-size, market-share, or forecast claims, ensuring that conclusions remain credible for strategic planning and industry intelligence.

Conclusion

The drug delivery devices market is entering a platform-driven era defined by self-administration, connected monitoring, biologics delivery, and AI-supported lifecycle management. Demand is supported by chronic disease prevalence, aging populations, expanding specialty therapeutics, and the need for convenient, accurate, and scalable treatment delivery across hospital, clinic, and home-care settings.

Winning organizations will combine regulatory discipline with patient-centered design, resilient manufacturing, digital security, sustainable engineering, and region-specific commercialization. As healthcare systems shift care closer to the patient, drug delivery devices will remain central to improving adherence, outcomes, treatment continuity, and access.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Drug Delivery Devices Market, by Product Type
7.1. Introduction
7.2. Injection Devices
7.2.1. Syringes
7.2.2. Pen Injectors
7.2.2.1. Disposable Pen Injectors
7.2.2.2. Reusable Pen Injectors
7.2.3. Autoinjectors
7.2.4. Needle-Free Injectors
7.3. Infusion Devices
7.3.1. External Infusion Pumps
7.3.1.1. Insulin Pumps
7.3.1.2. Ambulatory Infusion Pumps
7.3.2. Implantable Infusion Pumps
7.4. Inhalation Devices
7.4.1. Metered Dose Inhalers
7.4.2. Dry Powder Inhalers
7.5. Transdermal Delivery Devices
7.6. Implantable Devices
8. Drug Delivery Devices Market, by Therapeutic Area
8.1. Introduction
8.2. Metabolic Disorders
8.3. Oncology
8.3.1. Solid Tumors
8.3.2. Hematologic Malignancies
8.4. Cardiovascular Diseases
8.4.1. Hypertension
8.4.2. Heart Failure
8.5. Respiratory Diseases
8.6. Autoimmune And Inflammatory Diseases
8.7. Infectious Diseases
8.7.1. Viral Infections
8.7.2. Bacterial Infections
8.8. Neurological Disorders
8.9. Pain Management
8.10. Hormonal Disorders
9. Drug Delivery Devices Market, by Technology Platform
9.1. Introduction
9.2. Mechanical Delivery Systems
9.3. Electromechanical Devices
9.4. Biodegradable Polymer Systems
10. Drug Delivery Devices Market, by Application
10.1. Introduction
10.2. Diabetes
10.3. Oncology
10.4. Cardiovascular diseases
10.5. Pain management
11. Drug Delivery Devices Market, by End User
11.1. Introduction
11.2. Hospitals
11.3. Clinics
11.4. Ambulatory Surgical Centers
11.5. Home Care Settings
11.6. Diagnostic Centers
12. Drug Delivery Devices Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Drug Delivery Devices Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Drug Delivery Devices Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AdminMed nanoBioSciences LLC
16.2. AptarGroup, Inc.
16.3. ARx, LLC
16.4. Bayer AG
16.5. BioSerenTach Inc.
16.6. CosMED Pharmaceutical Co., Ltd.
16.7. Credence MedSystems, Inc.
16.8. E3D Elcam Drug Delivery Devices
16.9. Innoture Medical Technology Limited
16.10. Kindeva Drug Delivery L.P.
16.11. Luye Pharma Group?
16.12. Medtronic, Inc.
16.13. Midas Pharma GmbH
16.14. NanoPass Technologies Ltd.
16.15. Nitto Denko Corporation
16.16. Novartis AG?
16.17. Owen Mumford Limited
16.18. Recipharm AB
16.19. Sparsha Pharma International Pvt. Ltd.
List of Figures
FIGURE 1. GLOBAL DRUG DELIVERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DRUG DELIVERY DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DRUG DELIVERY DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DRUG DELIVERY DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INJECTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INJECTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SYRINGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SYRINGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SYRINGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PEN INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PEN INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PEN INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL AUTOINJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL AUTOINJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL INFUSION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL INFUSION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL INHALATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INHALATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL INHALATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SOLID TUMORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SOLID TUMORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SOLID TUMORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HYPERTENSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HYPERTENSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HYPERTENSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL HEART FAILURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HEART FAILURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 155. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 157. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 158. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 159. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 160. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 161. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 162. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 163. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 164. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 165. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 166. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 167. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 168. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 199. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 200. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 201. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 202. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 203. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 204. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 205. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 206. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 207. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 208. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 209. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 210. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 216. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 222. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 223. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 224. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 226. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 228. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 229. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 230. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 231. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 232. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 233. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 234. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 235. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 236. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 237. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 238. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 241. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 243. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 244. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 245. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 246. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 247. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 248. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 249. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 250. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 251. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 252. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 255. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 257. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 258. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 259. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 260. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 261. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 262. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 263. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 264. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 265. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 266. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 267. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 282. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 283. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 284. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 285. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 286. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 287. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 288. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 289. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 290. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 291. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 292. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 293. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 294. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 295. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 297. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 299. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 300. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 301. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 302. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 303. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 304. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 305. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 306. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 307. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 308. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 310. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 311. CHINA DRUG DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 313. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 314. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 315. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 316. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 317. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 318. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 319. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 320. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 321. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 322. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 323. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 324. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 327. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 328. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 329. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 330. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 331. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 332. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 333. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 334. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 335. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 336. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 337. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 338. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 339. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 340. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 341. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 342. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2017-2032 (USD MILLION)
TABLE 343. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 344. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 345. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 346. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 347. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 348. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2017-2032 (USD MILLION)
TABLE 349. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 350. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 351. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 352. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLI

Companies Mentioned

  • AdminMed nanoBioSciences LLC
  • AptarGroup, Inc.
  • ARx, LLC
  • Bayer AG
  • BioSerenTach Inc.
  • CosMED Pharmaceutical Co., Ltd.
  • Credence MedSystems, Inc.
  • E3D Elcam Drug Delivery Devices
  • Innoture Medical Technology Limited
  • Kindeva Drug Delivery L.P.
  • Luye Pharma Group​
  • Medtronic, Inc.
  • Midas Pharma GmbH
  • NanoPass Technologies Ltd.
  • Nitto Denko Corporation
  • Novartis AG​
  • Owen Mumford Limited
  • Recipharm AB
  • Sparsha Pharma International Pvt. Ltd.

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 470.89 Million
Forecasted Market Value ( USD ) by 2032 $ 767.54 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Connected Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Connected Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Pulmonary Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Pulmonary Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
COVID-19 Drug Delivery Devices - Global Strategic Business Report - Product Image

COVID-19 Drug Delivery Devices - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.